US4060082A
(en)
|
1976-08-16 |
1977-11-29 |
Mpl, Inc. |
Dual-ingredient medication dispenser
|
US4500513A
(en)
*
|
1979-05-15 |
1985-02-19 |
Miles Laboratories, Inc. |
Influenza vaccine production in liquid cell culture
|
SE8205892D0
(sv)
|
1982-10-18 |
1982-10-18 |
Bror Morein |
Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
|
IL73534A
(en)
|
1983-11-18 |
1990-12-23 |
Riker Laboratories Inc |
1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
|
US6090406A
(en)
|
1984-04-12 |
2000-07-18 |
The Liposome Company, Inc. |
Potentiation of immune responses with liposomal adjuvants
|
US5916588A
(en)
|
1984-04-12 |
1999-06-29 |
The Liposome Company, Inc. |
Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
|
US4680338A
(en)
|
1985-10-17 |
1987-07-14 |
Immunomedics, Inc. |
Bifunctional linker
|
US5011828A
(en)
|
1985-11-15 |
1991-04-30 |
Michael Goodman |
Immunostimulating guanine derivatives, compositions and methods
|
JPS62201573A
(ja)
|
1986-02-27 |
1987-09-05 |
Shionogi & Co Ltd |
家禽用インフルエンザワクチン
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
US4912094B1
(en)
|
1988-06-29 |
1994-02-15 |
Ribi Immunochem Research Inc. |
Modified lipopolysaccharides and process of preparation
|
AU631377B2
(en)
|
1988-08-25 |
1992-11-26 |
Liposome Company, Inc., The |
Affinity associated vaccine
|
US5238944A
(en)
|
1988-12-15 |
1993-08-24 |
Riker Laboratories, Inc. |
Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
|
US4929624A
(en)
|
1989-03-23 |
1990-05-29 |
Minnesota Mining And Manufacturing Company |
Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
|
WO1990014837A1
(en)
*
|
1989-05-25 |
1990-12-13 |
Chiron Corporation |
Adjuvant formulation comprising a submicron oil droplet emulsion
|
US4988815A
(en)
|
1989-10-26 |
1991-01-29 |
Riker Laboratories, Inc. |
3-Amino or 3-nitro quinoline compounds which are intermediates in preparing 1H-imidazo[4,5-c]quinolines
|
US5658731A
(en)
|
1990-04-09 |
1997-08-19 |
Europaisches Laboratorium Fur Molekularbiologie |
2'-O-alkylnucleotides as well as polymers which contain such nucleotides
|
US5389640A
(en)
|
1991-03-01 |
1995-02-14 |
Minnesota Mining And Manufacturing Company |
1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
SG46492A1
(en)
|
1991-03-01 |
1998-02-20 |
Minnesota Mining & Mfg |
1-Substituted 2-substituted 1H-imidazo [4,5-c] quinolin-4-amines
|
JPH0614756Y2
(ja)
|
1991-06-26 |
1994-04-20 |
株式会社アルテ |
組み立て式の2室式容器兼用注射器
|
US5936076A
(en)
|
1991-08-29 |
1999-08-10 |
Kirin Beer Kabushiki Kaisha |
αgalactosylceramide derivatives
|
US5268376A
(en)
|
1991-09-04 |
1993-12-07 |
Minnesota Mining And Manufacturing Company |
1-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
US5266575A
(en)
|
1991-11-06 |
1993-11-30 |
Minnesota Mining And Manufacturing Company |
2-ethyl 1H-imidazo[4,5-ciquinolin-4-amines
|
MY111880A
(en)
|
1992-03-27 |
2001-02-28 |
Smithkline Beecham Biologicals S A |
Hepatitis vaccines containing 3-0 deacylated monophosphoryl lipid a
|
IL105325A
(en)
|
1992-04-16 |
1996-11-14 |
Minnesota Mining & Mfg |
Immunogen/vaccine adjuvant composition
|
KR100278157B1
(ko)
|
1992-06-25 |
2001-01-15 |
장 스테판느 |
보조약을 함유하는 백신 조성물
|
US5395937A
(en)
|
1993-01-29 |
1995-03-07 |
Minnesota Mining And Manufacturing Company |
Process for preparing quinoline amines
|
DK0812593T4
(da)
|
1993-03-23 |
2008-05-13 |
Smithkline Beecham Biolog |
Vaccinepræparater indeholdende 3-O-deacyleret monophosphoryllipid-A
|
AU681687B2
(en)
|
1993-07-15 |
1997-09-04 |
Minnesota Mining And Manufacturing Company |
Imidazo(4,5-c)pyridin-4-amines
|
US5352784A
(en)
|
1993-07-15 |
1994-10-04 |
Minnesota Mining And Manufacturing Company |
Fused cycloalkylimidazopyridines
|
ES2370937T3
(es)
|
1993-09-13 |
2011-12-23 |
Protein Sciences Corporation |
Un método para producir vacunas antigripales polivalentes a base de hemaglutinina.
|
US5762939A
(en)
*
|
1993-09-13 |
1998-06-09 |
Mg-Pmc, Llc |
Method for producing influenza hemagglutinin multivalent vaccines using baculovirus
|
WO1995011700A1
(en)
|
1993-10-29 |
1995-05-04 |
Pharmos Corp. |
Submicron emulsions as vaccine adjuvants
|
GB9326174D0
(en)
|
1993-12-22 |
1994-02-23 |
Biocine Sclavo |
Mucosal adjuvant
|
GB9326253D0
(en)
|
1993-12-23 |
1994-02-23 |
Smithkline Beecham Biolog |
Vaccines
|
US6429199B1
(en)
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US5824536A
(en)
|
1994-08-23 |
1998-10-20 |
St. Jude Children's Research Hospital |
Influenza virus replicated in mammalian cell culture and vaccine production
|
US5496284A
(en)
|
1994-09-27 |
1996-03-05 |
Waldenburg; Ottfried |
Dual-chamber syringe & method
|
AUPM873294A0
(en)
|
1994-10-12 |
1994-11-03 |
Csl Limited |
Saponin preparations and use thereof in iscoms
|
JP3158157B2
(ja)
|
1994-11-10 |
2001-04-23 |
バクスター・アクチエンゲゼルシャフト |
無蛋白培養における生物製剤の製造法
|
US5482936A
(en)
|
1995-01-12 |
1996-01-09 |
Minnesota Mining And Manufacturing Company |
Imidazo[4,5-C]quinoline amines
|
GB9503863D0
(en)
|
1995-02-25 |
1995-04-19 |
Smithkline Beecham Biolog |
Vaccine compositions
|
UA56132C2
(uk)
|
1995-04-25 |
2003-05-15 |
Смітклайн Бічем Байолоджікалс С.А. |
Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
|
GB9620795D0
(en)
|
1996-10-05 |
1996-11-20 |
Smithkline Beecham Plc |
Vaccines
|
DE19612966B4
(de)
|
1996-04-01 |
2009-12-10 |
Novartis Vaccines And Diagnostics Gmbh & Co. Kg |
MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
|
DE19612967A1
(de)
|
1996-04-01 |
1997-10-02 |
Behringwerke Ag |
Verfahren zur Vermehrung von Influenzaviren in Zellkultur, sowie die durch das Verfahren erhältlichen Influenzaviren
|
AU3186297A
(en)
|
1996-07-05 |
1998-02-02 |
Debiotech S.A. |
Dual-chamber syringe for mixing two substances prior to injection
|
ATE292980T1
(de)
|
1996-10-11 |
2005-04-15 |
Univ California |
Immunostimulierende oligonucleotidekonjugate
|
AT405939B
(de)
|
1997-02-24 |
1999-12-27 |
Immuno Ag |
Verfahren zur inaktivierung von lipidumhüllten viren
|
WO1998040100A1
(en)
|
1997-03-10 |
1998-09-17 |
Ottawa Civic Loeb Research Institute |
USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE AS AN ADJUVANT
|
US6818222B1
(en)
|
1997-03-21 |
2004-11-16 |
Chiron Corporation |
Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants
|
TW570803B
(en)
|
1997-04-09 |
2004-01-11 |
Duphar Int Res |
Influenza vaccine
|
AU7126998A
(en)
|
1997-04-16 |
1998-11-11 |
Connaught Laboratories Inc. |
Anti-influenza compositions supplemented with neuraminidase
|
US6080725A
(en)
|
1997-05-20 |
2000-06-27 |
Galenica Pharmaceuticals, Inc. |
Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof
|
GB9711990D0
(en)
*
|
1997-06-11 |
1997-08-06 |
Smithkline Beecham Biolog |
Vaccine
|
GB9712347D0
(en)
|
1997-06-14 |
1997-08-13 |
Smithkline Beecham Biolog |
Vaccine
|
WO1999011241A1
(en)
|
1997-09-05 |
1999-03-11 |
Smithkline Beecham Biologicals S.A. |
Oil in water emulsions containing saponins
|
GB9718901D0
(en)
|
1997-09-05 |
1997-11-12 |
Smithkline Beecham Biolog |
Vaccine
|
AU9785598A
(en)
|
1997-10-03 |
1999-04-27 |
Texas Pharmaceuticals, Inc. |
Improved dual chamber syringe apparatus
|
US5971953A
(en)
|
1998-01-09 |
1999-10-26 |
Bachynsky; Nicholas |
Dual chamber syringe apparatus
|
GB9725084D0
(en)
|
1997-11-28 |
1998-01-28 |
Medeva Europ Ltd |
Vaccine compositions
|
AU756828B2
(en)
|
1997-12-02 |
2003-01-23 |
Powderject Vaccines, Inc. |
Transdermal delivery of particulate vaccine compositions
|
US6782510B1
(en)
|
1998-01-27 |
2004-08-24 |
John N. Gross |
Word checking tool for controlling the language content in documents using dictionaries with modifyable status fields
|
WO1999052549A1
(en)
|
1998-04-09 |
1999-10-21 |
Smithkline Beecham Biologicals S.A. |
Adjuvant compositions
|
NZ508013A
(en)
|
1998-05-07 |
2003-08-29 |
Corixa Corp |
Adjuvant composition for use with an antigen in a vaccine composition
|
US6562798B1
(en)
|
1998-06-05 |
2003-05-13 |
Dynavax Technologies Corp. |
Immunostimulatory oligonucleotides with modified bases and methods of use thereof
|
US6110929A
(en)
|
1998-07-28 |
2000-08-29 |
3M Innovative Properties Company |
Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
|
GB9817052D0
(en)
|
1998-08-05 |
1998-09-30 |
Smithkline Beecham Biolog |
Vaccine
|
DE19835749C1
(de)
|
1998-08-07 |
2000-02-03 |
Dieter Perthes |
Fertig-Spritze für nicht-stabile Arzneimittel
|
US6544785B1
(en)
|
1998-09-14 |
2003-04-08 |
Mount Sinai School Of Medicine Of New York University |
Helper-free rescue of recombinant negative strand RNA viruses
|
AT408615B
(de)
*
|
1998-09-15 |
2002-01-25 |
Immuno Ag |
Neue influenzavirus-impfstoffzusammensetzung
|
ATE357252T1
(de)
|
1998-10-16 |
2007-04-15 |
Glaxosmithkline Biolog Sa |
Adjuvanzsysteme und impfstoffe
|
US20030130212A1
(en)
|
1999-01-14 |
2003-07-10 |
Rossignol Daniel P. |
Administration of an anti-endotoxin drug by intravenous infusion
|
US6551600B2
(en)
|
1999-02-01 |
2003-04-22 |
Eisai Co., Ltd. |
Immunological adjuvant compounds compositions and methods of use thereof
|
US6355271B1
(en)
|
1999-02-03 |
2002-03-12 |
Biosante Pharmaceuticals, Inc. |
Therapeutic calcium phosphate particles and methods of manufacture and use
|
CA2689696C
(en)
*
|
1999-02-26 |
2013-08-06 |
Novartis Vaccines And Diagnostics, Inc. |
Microemulsions with adsorbed macromolecules and microparticles
|
ES2308069T3
(es)
|
1999-03-26 |
2008-12-01 |
Vical Incorporated |
Composiciones adyuvantes para realzar inmunorespuestas a las vacunas polinucleotido-basadas.
|
DE122008000061I1
(de)
*
|
1999-04-06 |
2009-02-12 |
Wisconsin Alumni Res Found |
Rekombinante influenzaviren zur vakzinherstellung und gentherapie
|
CZ303515B6
(cs)
|
1999-04-19 |
2012-11-07 |
Smithkline Beecham Biologicals S. A. |
Adjuvantní prostredek
|
US6331539B1
(en)
|
1999-06-10 |
2001-12-18 |
3M Innovative Properties Company |
Sulfonamide and sulfamide substituted imidazoquinolines
|
DE60033284T3
(de)
*
|
1999-07-14 |
2014-10-30 |
Icahn School Of Medicine At Mount Sinai |
In vitro-rekonstitution von segmentierten, negativstrang-rna-viren
|
EP1221971A2
(de)
|
1999-09-24 |
2002-07-17 |
SmithKline Beecham Biologics SA |
Verwendung der kombination von polyoxyethylen sorbitan ester und octoxynol als adjuvans und seine verwendung in impfstoffen
|
TR200200777T2
(tr)
|
1999-09-24 |
2002-09-23 |
Smithkline Beecham Biologicals S.A. |
Polioksietilen alkil eteri veya esteriyle en az bir iyonik olmayan yüzey aktif maddeli adjuvant.
|
ATE376825T1
(de)
|
1999-09-24 |
2007-11-15 |
Glaxosmithkline Biolog Sa |
Influenzavirus-impfstoffzusammensetzung zur nasalen anwendung
|
TR200503031T2
(tr)
|
1999-09-25 |
2005-09-21 |
University Of Iowa Research Foundation |
İmmünostimülatör nükleik asitler
|
GB9923176D0
(en)
|
1999-09-30 |
1999-12-01 |
Smithkline Beecham Biolog |
Novel composition
|
US20040109874A1
(en)
|
1999-11-10 |
2004-06-10 |
Powderject Vaccines, Inc. |
Induction of mucosal immunity by vaccination via the skin route
|
US20010044416A1
(en)
|
2000-01-20 |
2001-11-22 |
Mccluskie Michael J. |
Immunostimulatory nucleic acids for inducing a Th2 immune response
|
KR100797547B1
(ko)
|
2000-03-03 |
2008-01-24 |
자이단호진 가가쿠오요비겟세이료호겐쿠쇼 |
무혈청 배양 및 부유 배양에서 사용할 수 있는 세포 및상기 세포를 사용하여 백신용 바이러스를 제조하는 방법
|
WO2001080836A1
(fr)
|
2000-04-26 |
2001-11-01 |
Biovector Therapeutics |
Utilisation de vecteurs particulaires dans l'immunomodulation
|
IL152426A
(en)
|
2000-04-28 |
2011-07-31 |
St Jude Childrens Res Hospital |
A DNA transfection system to form an infectious negative-strand RNA virus
|
FR2808803B1
(fr)
|
2000-05-11 |
2004-12-10 |
Agronomique Inst Nat Rech |
Cellules es modifiees et gene specifique de cellules es
|
ES2334641T3
(es)
|
2000-09-01 |
2010-03-15 |
Novartis Vaccines And Diagnostics, Inc. |
Derivados aza heterociclicos y su uso terapeutico.
|
ES2302106T3
(es)
|
2000-09-11 |
2008-07-01 |
Novartis Vaccines And Diagnostics, Inc. |
Procedimiento de preparacion de derivados de bencimidazol-2-il quinolina.
|
AUPR007600A0
(en)
*
|
2000-09-13 |
2000-10-05 |
Kajlich, Anti |
Equipment for faster swimming pools
|
DE60132471T2
(de)
|
2000-09-26 |
2009-01-15 |
Idera Pharmaceuticals, Inc., Cambridge |
Modulation der immunostimulatorischen aktivität von immunostimulierenden oligonukleotidanaloga durch positionelle chemische veränderungen
|
GB0024089D0
(en)
|
2000-10-02 |
2000-11-15 |
Smithkline Beecham Biolog |
Novel compounds
|
GB0025577D0
(en)
|
2000-10-18 |
2000-12-06 |
Smithkline Beecham Biolog |
Vaccine
|
NZ525320A
(en)
|
2000-10-18 |
2004-10-29 |
Glaxosmithkline Biolog S |
Combinations of immunostimulatory oligonucleotides (CpG), saponin and optionally lipopolysaccharides as potent vaccine adjuvants
|
US6664265B2
(en)
|
2000-12-08 |
2003-12-16 |
3M Innovative Properties Company |
Amido ether substituted imidazoquinolines
|
UA74852C2
(en)
|
2000-12-08 |
2006-02-15 |
3M Innovative Properties Co |
Urea-substituted imidazoquinoline ethers
|
US6664260B2
(en)
|
2000-12-08 |
2003-12-16 |
3M Innovative Properties Company |
Heterocyclic ether substituted imidazoquinolines
|
US6660747B2
(en)
|
2000-12-08 |
2003-12-09 |
3M Innovative Properties Company |
Amido ether substituted imidazoquinolines
|
US6664264B2
(en)
|
2000-12-08 |
2003-12-16 |
3M Innovative Properties Company |
Thioether substituted imidazoquinolines
|
US6677348B2
(en)
|
2000-12-08 |
2004-01-13 |
3M Innovative Properties Company |
Aryl ether substituted imidazoquinolines
|
US6677347B2
(en)
|
2000-12-08 |
2004-01-13 |
3M Innovative Properties Company |
Sulfonamido ether substituted imidazoquinolines
|
US6660735B2
(en)
|
2000-12-08 |
2003-12-09 |
3M Innovative Properties Company |
Urea substituted imidazoquinoline ethers
|
US6667312B2
(en)
|
2000-12-08 |
2003-12-23 |
3M Innovative Properties Company |
Thioether substituted imidazoquinolines
|
US7018638B2
(en)
|
2000-12-19 |
2006-03-28 |
Wyeth |
Mycoplasma hyopneumoniae bacterin vaccine
|
WO2002074336A2
(en)
|
2001-02-23 |
2002-09-26 |
Glaxosmithkline Biologicals S.A. |
Influenza vaccine formulations for intradermal delivery
|
WO2002067983A1
(en)
|
2001-02-23 |
2002-09-06 |
Glaxosmithkline Biologicals S.A. |
Novel vaccine
|
WO2002072012A2
(en)
|
2001-03-09 |
2002-09-19 |
Id Biomedical Corporation Of Quebec |
A novel proteosome-liposaccharide vaccine adjuvant
|
MY134424A
(en)
|
2001-05-30 |
2007-12-31 |
Saechsisches Serumwerk |
Stable influenza virus preparations with low or no amount of thiomersal
|
US7361352B2
(en)
|
2001-08-15 |
2008-04-22 |
Acambis, Inc. |
Influenza immunogen and vaccine
|
DE10144906B4
(de)
|
2001-09-12 |
2013-11-28 |
Novartis Vaccines And Diagnostics Gmbh |
Verfahren zur großtechnischen Herstellung von Impfstoffen
|
DE10144903A1
(de)
|
2001-09-12 |
2003-03-27 |
Chiron Behring Gmbh & Co |
Vermehrung von Viren in Zellkultur
|
WO2003035836A2
(en)
|
2001-10-24 |
2003-05-01 |
Hybridon Inc. |
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
|
FR2832423B1
(fr)
|
2001-11-22 |
2004-10-08 |
Vivalis |
Systeme d'expression de proteines exogenes dans un systeme aviaire
|
US7321033B2
(en)
|
2001-11-27 |
2008-01-22 |
Anadys Pharmaceuticals, Inc. |
3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof
|
KR100718371B1
(ko)
|
2001-11-27 |
2007-05-14 |
애나디스 파마슈티칼스, 인코포레이티드 |
3-β-D-리보푸라노실티아졸로[4,5-d]피리디민누클레오시드 및 이의 용도
|
US6677349B1
(en)
|
2001-12-21 |
2004-01-13 |
3M Innovative Properties Company |
Sulfonamide and sulfamide substituted imidazoquinolines
|
FR2836924B1
(fr)
|
2002-03-08 |
2005-01-14 |
Vivalis |
Lignees de cellules aviaires utiles pour la production de substances d'interet
|
US6861410B1
(en)
*
|
2002-03-21 |
2005-03-01 |
Chiron Corporation |
Immunological adjuvant compositions
|
SI1499311T1
(sl)
|
2002-03-29 |
2010-03-31 |
Novartis Vaccines & Diagnostic |
Substituirani benzazoli in njihova uporaba kot inhibitorji Raf kinaze
|
JP2005531599A
(ja)
|
2002-05-29 |
2005-10-20 |
スリーエム イノベイティブ プロパティズ カンパニー |
イミダゾ[4,5−c]ピリジン−4−アミンのための方法
|
AU2003251518B2
(en)
|
2002-06-13 |
2009-07-02 |
New York University |
Synthetic C-glycolipid and its use for treating cancer infectious diseases and autoimmune diseases
|
WO2004018455A1
(en)
|
2002-08-23 |
2004-03-04 |
Chiron Corporation |
Pyrrole based inhibitors of glycogen synthase kinase 3
|
US7521062B2
(en)
|
2002-12-27 |
2009-04-21 |
Novartis Vaccines & Diagnostics, Inc. |
Thiosemicarbazones as anti-virals and immunopotentiators
|
ES2391770T3
(es)
|
2003-01-21 |
2012-11-29 |
Novartis Vaccines And Diagnostics, Inc. |
Uso de compuestos de triptantrina para la potenciación inmune
|
GB0301554D0
(en)
|
2003-01-23 |
2003-02-26 |
Molecularnature Ltd |
Immunostimulatory compositions
|
JP2006521321A
(ja)
|
2003-03-24 |
2006-09-21 |
インターツェル・アクチェンゲゼルシャフト |
免疫応答を促進するためのミョウバンおよびTh1免疫応答誘起アジュバントの使用
|
EP2258365B1
(de)
|
2003-03-28 |
2013-05-29 |
Novartis Vaccines and Diagnostics, Inc. |
Verwendung von organischen verbindungen zur immunstärkung
|
US7731967B2
(en)
|
2003-04-30 |
2010-06-08 |
Novartis Vaccines And Diagnostics, Inc. |
Compositions for inducing immune responses
|
MXPA06000942A
(es)
|
2003-07-24 |
2006-03-30 |
Merial Ltd |
Nuevas formulaciones de vacunas.
|
RU2236257C1
(ru)
|
2003-09-15 |
2004-09-20 |
Косяков Константин Сергеевич |
Синтетический иммуноген для терапии и профилактики злоупотреблений наркотическими и психоактивными веществами
|
US7771726B2
(en)
|
2003-10-08 |
2010-08-10 |
New York University |
Use of synthetic glycolipids as universal adjuvants for vaccines against cancer and infectious diseases
|
EP1528101A1
(de)
|
2003-11-03 |
2005-05-04 |
ProBioGen AG |
Immortalisierte Vogel-Zelllinien für die Produktion von Viren
|
US8673634B2
(en)
|
2003-11-13 |
2014-03-18 |
Massachusetts Eye & Ear Infirmary |
Method for the treatment of hearing loss
|
EP1550458A1
(de)
|
2003-12-23 |
2005-07-06 |
Vectron Therapeutics AG |
Synergisitische liposomale Adjuvantien
|
DE202005022108U1
(de)
*
|
2004-03-09 |
2013-11-12 |
Novartis Vaccines And Diagnostics, Inc. |
Influenza-Virus-Impfstoffe
|
JP5003155B2
(ja)
|
2004-03-23 |
2012-08-15 |
ニプロ株式会社 |
プレフィルドシリンジ
|
JP2007531768A
(ja)
|
2004-03-31 |
2007-11-08 |
ニューヨーク・ユニバーシティ |
感染症、癌および自己免疫疾患を治療するための新規な合成c−糖脂質、その合成および使用
|
JP5393978B2
(ja)
|
2004-04-05 |
2014-01-22 |
ゾエティス・ピー・エルエルシー |
マイクロ流動化された水中油型乳剤及びワクチン組成物
|
WO2005113756A1
(en)
|
2004-05-14 |
2005-12-01 |
Glaxosmithkline Biologicals S.A. |
Method
|
KR20070060049A
(ko)
|
2004-05-20 |
2007-06-12 |
아이디 바이오메디칼 코포레이션 |
인플루엔자 백신의 제조방법
|
CA2565500A1
(en)
|
2004-05-28 |
2005-12-15 |
Glaxosmithkline Biologicals S.A. |
Vaccine compositions comprising virosomes and a saponin adjuvant
|
JP2008504292A
(ja)
|
2004-06-24 |
2008-02-14 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス, インコーポレイテッド |
免疫増強用の化合物
|
DE102004032251B4
(de)
|
2004-07-03 |
2008-05-29 |
Daimler Ag |
Vorrichtung zur Abscheidung von Wasser und zur Ausfilterung von Verunreinigungen
|
ES2386272T3
(es)
|
2004-09-09 |
2012-08-16 |
Novartis Vaccines And Diagnostics Gmbh |
Reducción de riesgos iatrogénicos potenciales asociados a las vacunas antigripales
|
US20070292386A9
(en)
|
2004-12-02 |
2007-12-20 |
Campbell Robert L |
Vaccine formulations for intradermal delivery comprising adjuvants and antigenic agents
|
ATE547511T1
(de)
|
2004-12-23 |
2012-03-15 |
Medimmune Llc |
Nichttumorbildende mdck-zellinie zur vermehrung von viren
|
BRPI0518568A2
(pt)
|
2004-12-24 |
2008-11-25 |
Solvay Pharm Bv |
mÉtodo para produzir uma partÍcula do vÍrus da influenza replicativo sem o uso de vÍrus auxiliar, partÍcula de vÍrus da influenza replicativo, cÉlula, composiÇço, uso de uma composiÇço, mÉtodo para gerar proteÇço imunolàgica contra infecÇço de um indivÍduo com um vÍrus da influenza, e, Ácido nuclÉico
|
PT1861120T
(pt)
|
2005-03-23 |
2016-08-18 |
Glaxosmithkline Biologicals Sa |
Utilização de um vírus influenza e de um adjuvante de emulsão óleo-em-água para induzir células t cd4 e/ou melhorar a resposta de células b de memória
|
FR2884255B1
(fr)
|
2005-04-11 |
2010-11-05 |
Vivalis |
Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe
|
US7691368B2
(en)
|
2005-04-15 |
2010-04-06 |
Merial Limited |
Vaccine formulations
|
AR054822A1
(es)
|
2005-07-07 |
2007-07-18 |
Sanofi Pasteur |
Emulsion inmuno adyuvante
|
JP2009500869A
(ja)
|
2005-07-11 |
2009-01-08 |
ブルックス オートメーション インコーポレイテッド |
オンザフライ(onthefly)ワークピースセンタリングを備えた装置
|
US7384642B2
(en)
*
|
2005-08-25 |
2008-06-10 |
Merial Limited |
Canine influenza vaccines
|
US7425336B2
(en)
*
|
2005-08-25 |
2008-09-16 |
Mevial Limited |
Canine influenza vaccines
|
EA014190B1
(ru)
*
|
2005-11-04 |
2010-10-29 |
Новартис Вэксинс Энд Диагностикс Срл |
Вакцины против гриппа, адсорбированные на алюминиевых адъювантах, для немедленного приёма
|
WO2007052059A2
(en)
*
|
2005-11-04 |
2007-05-10 |
Novartis Vaccines And Diagnostics Srl |
Changing th1/th2 balance in split influenza vaccines with adjuvants
|
ES2401484T3
(es)
*
|
2006-06-15 |
2013-04-22 |
Novartis Ag |
Régimen de vacunación contra la gripe multidosis ahorrador de adyuvantes
|
KR20090057015A
(ko)
|
2006-09-11 |
2009-06-03 |
노파르티스 아게 |
난을 사용하지 않는 인플루엔자 바이러스 백신의 제조
|
PE20090146A1
(es)
|
2007-04-20 |
2009-03-23 |
Glaxosmithkline Biolog Sa |
Composicion inmunogenica contra el virus influenza
|
US8506966B2
(en)
*
|
2008-02-22 |
2013-08-13 |
Novartis Ag |
Adjuvanted influenza vaccines for pediatric use
|
SI2506834T1
(sl)
*
|
2009-12-03 |
2016-04-29 |
Novartis Ag |
Cirkulacija sestavin med homogenizacijo in mikrofluidizacijo emulzij
|